Dr. Ahmed is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Advent Health Neuroscience institute
265 E Rollins Street, 6th Floor
Orlando, FL 32804Phone+1 407-303-6729Fax+1 407-628-2037
Summary
- Dr. Anwar Ahmed is a neurologist based in Orlando, FL, with a subspecialty in movement disorders. He completed his residency in neurology at Detroit Medical Center/Wayne State University and a transitional year internship at Icahn School of Medicine. Dr. Ahmed has been serving as a team doctor at Cleveland Clinic Health System since 2000. He possesses extensive experience in general neurology, movement disorders, meige syndrome, spasmodic torticollis, and clinical neurophysiology. He has published several notable studies, including research on Parkinson's disease and progressive supranuclear palsy, and has participated in various clinical trials as a principal investigator. In 2019, he was recognized as a Fellow of the American Academy of Neurology.
Education & Training
Detroit Medical Center/Wayne State UniversityResidency, Neurology, 1996 - 1999
Icahn School of Medicine at Mount Sinai (NYC Health + Hospitals: Elmhurst)Internship, Transitional Year, 1995 - 1996
Dow University of Health SciencesClass of 1993
Certifications & Licensure
FL State Medical License 2020 - 2026
OH State Medical License 2000 - 2025
AZ State Medical License 2004 - 2010- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Fellow of American Academy of Neurology American Academy of Neurology, 2019
Clinical Trials
- Neurobiological Predictors of Huntington's Disease (PREDICT-HD) Start of enrollment: 2002 Aug 01
- Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E) Start of enrollment: 2009 Sep 01
- Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression Start of enrollment: 2010 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 62 citationsSafety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial.Günter U. Höglinger, Irene Litvan, Nuno Mendonca, Deli Wang, Hui Zheng
The Lancet. Neurology. 2021-03-01 - 89 citationsEfficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease: A Randomized Clinical Trial.Tanya Simuni, Brian K. Fiske, Kalpana Merchant, Christopher S. Coffey, Elizabeth A. Klingner
JAMA Neurology. 2021-03-01 - 10 citationsFactors Associated With Postoperative Confusion and Prolonged Hospital Stay Following Deep Brain Stimulation Surgery for Parkinson DiseaseHesham Abboud, Gençer Genç, Saira Saad, Nicolas R. Thompson, Srivadee Oravivattanakul
Neurosurgery. 2019-08-20
Professional Memberships
- Member
- Member
- American Neurological AssociationMember
- Society for NeuroscienceMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
